-
Most Recent
Search Results
240 results for COV
Why Is LumiraDx (LMDX) Stock Up 30% Today?
LumiraDx (LMDX) stock is heading higher on Wednesday morning after the company received approval for its Covid and RSV tests.
The Inflation Number Warsh Is Actually Watching
Micron earnings shatter records… PCE inflation hits 4.1%… but what about the inflation number Warsh is watching?… are we only in the 3rd inning of…
8 Healthcare Stocks to Sell
To keep you from getting into the wrong healthcare care companies or sticking with some sickly stocks, here’s my list of 8 big-name medical companies…
7 Software Stocks to Sell Now
This week, the overall grades of seven software stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
8 Software Stocks to Sell Now
This week, 8 Software stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
FedEx Flies, Discover Dives — Thursday’s IP Market Recap
Both beat earnings estimates, but then went separate ways.
Target Highly Promising Antiviral Therapeutics with Cocrystal Pharma
A buying opportunity is here as COCP stock is down, even as Cocrystal makes progress in developing a potentially lifesaving antiviral drug.
7 Medical Devices Stocks to Buy Now
The grades of seven Medical Devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong…
SoftBank Calls AI 50x Bigger Than Dot-Com — Here’s Who Actually Profits
To understand why Masayoshi Son is so confident in AI’s future, it’s worth taking a closer look at where SoftBank is actually putting its money…
Hold Merck for Its Solid Dividend and Covid-19 Treatment Prospects
MRK stock might not be an obvious “vaccine stock,” but Merck’s commitment to combating Covid-19 is commendable and potentially profitable.
Windows of Opportunity Are Tightening for Sorrento Therapeutics
Thanks to Sorrento Therapeutics’ all-out pivot to address the Covid-19 pandemic, SRNE stock initially became one of the most popular investments. But as both the…
9 Software Stocks to Sell Now
This week, 9 Software stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
10 Software Stocks to Sell Now
The ratings of 10 Software stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
PDSB Stock: Why PDS Biotech Is Blasting Higher Today
PDS Biotech (PDSB) stock is heading higher on Thursday after announcing funding for the company’s vaccine for the novel coronavirus.
HOTH Stock: The News That Has Biopharma Hoth Therapeutics Shooting Higher Today
Shares of HOTH stock are blasting off on Tuesday morning after strong preclinical results from the firm’s coronavirus treatment.
You Still Don’t Want to Sail Aboard Carnival Stock
While some news points to a comeback potential for Carnival stock, conservative investors should still hold off on this risky sector.
ADGI Stock Soars as Analysts Lock On to Its Omicron-Fighting Potential
Shares of ADGI stock are soaring higher by 80% after the company stated that its ADG-20 antibody is effective against the omicron variant.
REGN Stock: Regeneron Pops on Trump’s Antibody Support
With Trump’s support, Regeneron just filed for emergency-use authorization with the FDA. REGN stock is climbing on the news.
3 Crash-Proof Medical Stocks to Keep Your Portfolio’s Pulse
The recent rally won’t last forever, but investors wanting to jump in can still do so — and protect themselves — by getting into these…
Why the Pandemic Could Once Again Trouble Norwegian Cruise Line
While bulls of NCLH stock are eager to see the travel industry normalize, an old enemy may once again be waiting at the docks.
5 – 10 of 240 results
